2022
DOI: 10.1016/j.jval.2022.04.1736
|View full text |Cite
|
Sign up to set email alerts
|

A Simulation-Based Cost-Effectiveness Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Prevention Strategies for Visitors of Healthcare Institutions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 26 publications
0
4
0
1
Order By: Relevance
“…Data Science) zuzuordnen. Simulationsstudien wurden etwa zur Bettenkapazitätssteuerung in Krankenhäusern während der Pandemie [ 24 ], zur Evaluation von Besuchsmanagementstrategien in Gesundheitseinrichtungen [ 7 ] oder zur OP-Planung [ 48 ] eingesetzt. Vorteil von Computersimulationen ist es, dass auf der Basis von realen oder simulierten Daten verschiedene Entscheidungsalternativen bzw.…”
Section: Datenwissenschaftliche Evaluation Unterschiedlicher Zuteilun...unclassified
“…Data Science) zuzuordnen. Simulationsstudien wurden etwa zur Bettenkapazitätssteuerung in Krankenhäusern während der Pandemie [ 24 ], zur Evaluation von Besuchsmanagementstrategien in Gesundheitseinrichtungen [ 7 ] oder zur OP-Planung [ 48 ] eingesetzt. Vorteil von Computersimulationen ist es, dass auf der Basis von realen oder simulierten Daten verschiedene Entscheidungsalternativen bzw.…”
Section: Datenwissenschaftliche Evaluation Unterschiedlicher Zuteilun...unclassified
“…Throughout the coronavirus disease 2019 (COVID-19) pandemic, environments with a high density of inhabitants, such as hospitals, assisted living facilities, cruise ships, schools, and universities have been identified as particularly prone to outbreaks . Close proximity and frequent interactions in those environments can facilitate the transmission of the etiological agent, that is, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). , Since 2020, various national and international guidance and policy documents have recommended continuous monitoring of such environs to minimize the emergence of local COVID-19 clusters and outbreaks. Clinical diagnostics using antigen tests and nasopharyngeal swabbing proved successful in mitigating outbreaks by identifying and localizing symptomatic and asymptomatic virus carriers in universities and hospitals . However, the invasive nature of nasal swabs, high per-person costs, and bottlenecks due to the limited capacities of test kits and the necessity for the cooperation of individuals make the continuous use of clinical diagnostic kits impractical for an endemic COVID-19 future …”
Section: Introductionmentioning
confidence: 99%
“…4−7 Clinical diagnostics using antigen tests and nasopharyngeal swabbing proved successful in mitigating outbreaks by identifying and localizing symptomatic and asymptomatic virus carriers in universities 8−10 and hospitals. 11 However, the invasive nature of nasal swabs, high per-person costs, and bottlenecks due to the limited capacities of test kits and the necessity for the cooperation of individuals make the continuous use of clinical diagnostic kits impractical for an endemic COVID-19 future. 12 Wastewater SARS-CoV-2 levels are well-established to reflect the SARS-CoV-2 burden in a population.…”
Section: ■ Introductionmentioning
confidence: 99%
“…Despite more than 2 years having passed since the start of the health crisis, the economic and social levels reached in December 2019 have still not been achieved [ 21 , 22 , 23 ]. Although research efforts are being made extensively in this field, only a limited number of studies describing the economic impact of this disease are available [ 4 , 24 , 25 , 26 , 27 , 28 ]. There is considerable heterogeneity across costing methodologies (simulation, absolute costs, etc.).…”
Section: Introductionmentioning
confidence: 99%
“…There is considerable heterogeneity across costing methodologies (simulation, absolute costs, etc.). We observed a great variation in costs per patient, making comparison challenging even among countries with similar economic status [ 26 , 27 , 28 ]. However, no studies have performed a comparative analysis of ‘intra-hospital’ costs, especially for the costs incurred in important areas such as the emergency department, hospitalisation, and intensive care unit of the same hospital, between 2019 (pre-pandemic) and 2020 (first year of the pandemic).…”
Section: Introductionmentioning
confidence: 99%